跳至主要内容
临床试验/NCT01640197
NCT01640197已完成1 期

The Effects of Chronic Trans- Resveratrol Supplementation on Aspects of Cognitive Performance, Mood, Sleep, Health and Cerebral Blood Flow in Healthy, Young Humans.

Northumbria University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年2月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Chronic Modulation of Cerebral Blood Flow

研究概览

简要总结

The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Between 18-35
  • •At least enrolled on undergraduate degree programme
  • •Native English speaker

排除标准

  • •Taking other medication/ supplements
  • •Pregnant/ breast feeding
  • •High caffeine consumers
  • •Migraine sufferers

研究组 & 干预措施

Placebo

Placebo Comparator

Methyl Cellulose administered in identical capsules as the active.

干预措施: Placebo (Other)

500mg resveratrol

Active Comparator

Transmax from biotivia. 500mg resveratrol (98% purity) with 10mg piperine per capsule. 1 capsule taken daily.

干预措施: Resveratrol (Dietary Supplement)

结局指标

主要结局

Chronic Modulation of Cerebral Blood Flow

时间窗: 40- 80 minutes post- dose on day 28 of supplementation

Cerebral blood flow (CBF) was measured in the frontal cortex with Near-Infrared Spectroscopy (NIRS). Modulation was deemed to have taken place if levels differed significantly from day 1 to day 28.

次要结局

  • Number of Participants With Modulated Mood(28 days)
  • Number of Participants With Modulated Cognitive Performance(28 days)
  • Number of Participants With Significant Modulation of Sleep(Day 28)
  • Number of Participants With Significant Modulation of Health(Day 28)
  • Number of Participants With Significant Modulation of Blood Pressure(28 days)
  • Number of Participants With Significant Modulation of CBF in MCA(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Kennedy

Professor

Northumbria University

研究点 (1)

Loading locations...

相似试验